Accuracy of an electronic monitoring and reminder device for use with travoprost eye drops

J Glaucoma. 2006 Feb;15(1):30-4. doi: 10.1097/01.ijg.0000196654.77836.61.

Abstract

Purpose: To evaluate the accuracy of a prototype electronic device for recording eye drop usage.

Participants and methods: Ten volunteers were randomly assigned to one of five usage patterns designed to mimic common patterns of use in glaucoma patients from 100% compliant to 50% compliant. All participants agreed to adhere to a pre-determined "dosing" schedule for 15 days using the monitoring/reminder device to instill artificial tears. Participants also recorded drop usage in a diary. The main outcome measures were device accuracy and reproducibility. Device accuracy was defined as the magnitude of the difference between the diary and device output for three variables: date, number of drops, and instillation time.

Results: Date stamping by the device was 100% accurate. The mean +/- SD time difference between the device and the diary was -2.0 +/- 19.7 minutes when data from all participants was pooled. In seven of the ten participants, the device did not record at least one drop. The mean +/- SD difference in the number of drops recorded by the device minus the diary was 0.16 +/- 0.97 when data from all participants was pooled.

Conclusions: The prototype compliance reminder/monitoring device may underestimate compliance in some patients. The date and time stamping mechanisms were generally accurate and reproducible.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antihypertensive Agents / administration & dosage*
  • Cloprostenol / administration & dosage
  • Cloprostenol / analogs & derivatives*
  • Drug Utilization
  • Glaucoma / drug therapy*
  • Humans
  • Monitoring, Ambulatory / instrumentation*
  • Monitoring, Ambulatory / methods
  • Ophthalmic Solutions / administration & dosage*
  • Patient Compliance*
  • Reproducibility of Results
  • Travoprost

Substances

  • Antihypertensive Agents
  • Ophthalmic Solutions
  • Cloprostenol
  • Travoprost